INO 2002
Alternative Names: IMS; Inosine analogue - Rocket; Inosinergic agonist - RocketLatest Information Update: 02 Oct 2021
At a glance
- Originator Inotek Pharmaceuticals
- Class Nucleosides
- Mechanism of Action Chemokine receptor antagonists; Cytokine inhibitors; NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rheumatoid arthritis; Ulcerative colitis
Most Recent Events
- 04 Jan 2018 Rocket Pharmaceuticals merged with Inotek Pharmaceuticals and the combined company was named Rocket Pharmaceuticals
- 13 Sep 2007 Discontinued - Phase-I for Ulcerative colitis in USA (PO)
- 13 Sep 2007 Discontinued - Preclinical for Rheumatoid arthritis in USA (PO)